PTCT : Insider Transactions for PTC Therapeutics, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

PTC Therapeutics, Inc. (PTCT)

$75.53

0.90 (1.18%) as of 4:30 Fri 1/30

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

90,552,000

Market Cap:

6.84(B)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$36.19 - $86.25

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 557

Guru Rank Value : 3.3

Guru Occurances : 1


6 Months 1 Year 2 Year

Company Profile PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Co. has the following products, Translarna™ (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, a rare, life threatening disorder. Co.'s gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS) include PTC- Aromatic L-Amino Acid Decarboxylase (AADC) for the treatment of AADC deficiency, a rare CNS disorder arising from reductions in the enzyme AADC that results from mutations in the dopa decarboxylase gene.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	290,283	556,830	681,208	946,990
Total Sell Value	$22,992,531	$39,602,340	$46,128,481	$59,295,737
Total People Sold	10	11	12	13
Total Sell Transactions	40	55	82	110
End Date	2025-11-02	2025-08-01	2025-01-31	2024-02-01

Adjust Filter Settings

Records found: 621

Page 1 of 25

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

CHIEF BUSINESS OFFICER

• – –

2026-01-12

4

AS

$78.70

$80,589

D/D

(1,024)

80,141

-3%

CHIEF BUSINESS OFFICER

• – –

2026-01-09

4

AS

$77.41

$133,300

D/D

(1,722)

81,165

-3%

Boulding Mark Elliott

EXEC. VP AND CLO

• – –

2026-01-09

4

AS

$77.46

$180,320

D/D

(2,314)

111,312

-3%

CHIEF BUSINESS OFFICER

• – –

2026-01-08

4

AS

$76.42

$352,057

D/D

(4,602)

82,887

-2%

Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

• – –

2026-01-08

4

S

$76.45

$4,511

I/I

(59)

6,791

1%

Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

• – –

2026-01-08

4

S

$76.45

$67,352

D/D

(881)

115,196

1%

Utter Christine Marie

SVP, CHIEF ACCOUNTING OFFICER

• – –

2026-01-08

4

S

$76.45

$79,049

D/D

(1,034)

72,693

1%

Golden Lee Scott

EVP & CHIEF MEDICAL OFFICER

• – –

2026-01-08

4

S

$76.45

$66,206

D/D

(866)

92,428

1%

Boulding Mark Elliott

EXEC. VP AND CLO

• – –

2026-01-08

4

AS

$76.45

$308,760

D/D

(4,033)

113,626

-2%

Klein Matthew B.

CHIEF EXECUTIVE OFFICER

• • –

2026-01-08

4

S

$76.45

$192,195

D/D

(2,514)

394,453

1%

Boulding Mark Elliott

EXEC. VP AND CLO

• – –

2026-01-07

4

AS

$77.10

$377,825

D/D

(4,879)

117,659

-2%

Boulding Mark Elliott

EXEC. VP AND CLO

• – –

2026-01-07

4

OE

$38.10

$128,626

D/D

3,376

118,410

-

Golden Lee Scott

EVP & CHIEF MEDICAL OFFICER

• – –

2026-01-07

4

S

$77.48

$49,742

D/D

(642)

93,294

1%

CHIEF BUSINESS OFFICER

• – –

2026-01-07

4

S

$77.48

$104,753

D/D

(1,352)

87,489

1%

Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

• – –

2026-01-07

4

S

$77.48

$4,029

I/I

(52)

6,850

1%

Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

• – –

2026-01-07

4

S

$77.48

$79,494

D/D

(1,026)

116,077

1%

Klein Matthew B.

CHIEF EXECUTIVE OFFICER

• • –

2026-01-07

4

S

$77.48

$233,680

D/D

(3,016)

396,967

1%

Utter Christine Marie

SVP, CHIEF ACCOUNTING OFFICER

• – –

2026-01-07

4

S

$77.45

$95,651

D/D

(1,235)

73,727

1%

Boulding Mark Elliott

EXEC. VP AND CLO

• – –

2026-01-06

4

AS

$76.95

$133,816

D/D

(1,739)

119,162

-2%

Golden Lee Scott

EVP & CHIEF MEDICAL OFFICER

• – –

2026-01-06

4

S

$76.95

$103,113

D/D

(1,340)

93,936

0%

CHIEF FINANCIAL OFFICER

• – –

2026-01-06

4

S

$76.95

$164,596

D/D

(2,139)

90,310

0%

CHIEF BUSINESS OFFICER

• – –

2026-01-06

4

S

$76.95

$137,664

D/D

(1,789)

88,841

0%

Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

• – –

2026-01-06

4

S

$76.95

$4,155

I/I

(54)

6,902

0%

Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

• – –

2026-01-06

4

S

$76.95

$98,419

D/D

(1,279)

117,103

0%

Klein Matthew B.

CHIEF EXECUTIVE OFFICER

• • –

2026-01-06

4

S

$76.95

$396,216

D/D

(5,149)

399,983

0%

621 Records found	1 2 3 4 5 6 7 8 9 Next	Page 1 of 25

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2026 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.